Come see clinical data for ENHERTU® (fam-trastuzumab deruxtecan-nxki)

December 7, 2023 @ 12:30 pm 1:30 pm CST

Presented by Daiichi Sankyo, Inc. and AstraZeneca

Program Description

Please join us for an informative, expert-led Product Theater presented by Daiichi Sankyo, Inc. and AstraZeneca to learn about the clinical data for ENHERTU.

Please click here for full Prescribing Information, including Boxed WARNINGS for Interstitial Lung Disease/Pneumonitis and Embryo-Fetal Toxicity, and Medication Guide, or visit

ENHERTU® is a registered trademark of Daiichi Sankyo Company, Limited. © 2023 Daiichi Sankyo, Inc. and AstraZeneca. PP-US-ENB-2936 10/23

This Exhibitor Product Theater is a promotional activity and is not approved for continuing education credit. The content of this Exhibitor Product Theater and opinions expressed by presenters are those of the sponsor or presenter and are not of the San Antonio Breast Cancer Symposium® (SABCS).

Anne O’Dea, MD
University of Kansas Cancer Center
Medical Director
Kansas City, KS